Floatz logo

Lcar-Aio T Cells

Neuromyelitis Optica Spectrum Disease (NMOSD)

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCell therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

18 Active assets in the Neuromyelitis Optica Spectrum Disease (NMOSD) cohort.

Asset / SponsorPhaseRating
CARMUSTINE
Fred Hutchinson Cancer Center
Phase 2CCC
Cytosin-Arabinosid
Fred Hutchinson Cancer Center
Phase 2CCC
Evomela
Fred Hutchinson Cancer Center
Phase 2CCC
Anti-Thymoglobulin, Rabbit
Fred Hutchinson Cancer Center
Phase 2CCC
ETOPOSIDE
Fred Hutchinson Cancer Center
Phase 2CCC

View all 20 →

Same molecule, other indications

Lcar-Aio T Cells is also rated in:

multiple sclerosisDormant
CC
Indicative ·
43 / 100
View asset →
myelin oligodendrocyte glycoprotein antibody-associated diseaseDormant
CC
Indicative ·
43 / 100
View asset →
myasthenia gravisDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →